Jonathan Weissman


Jonathan S. Weissman is a Professor of Cellular Molecular Pharmacology at the University of California, San Francisco. He has been affiliated with the Howard Hughes Medical Institute since 2000; first, as an Assistant Investigator and, since 2005, as an Investigator.

Education

He earned his B.A. in Physics from Harvard College and his Ph.D. in Physics from MIT working with Peter Kim. There, he started his studies on protein folding examining Bovine pancreatic trypsin inhibitor.
He was a postdoctoral fellow at Yale University, where he worked with Arthur Horwich studying the mechanism of GroEL.

Career

Weissman's research team studies how cells ensure that proteins fold into their correct shape, as well as the role of protein misfolding in disease and normal physiology. The team also develops experimental and analytical approaches for exploring the organizational principles of biological systems and globally monitoring protein translation through ribosome profiling. A broad goal of his work is to bridge large-scale approaches and in depth mechanistic investigations to reveal the information encoded within genomes..
Weissman has been a member of the National Academy of Sciences since 2009.